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Edited by Felix WeilandAbstract It has been suggested that syntaxin 5 (Syx5) partici-
pates in vesicular transport. We examined the eﬀects of Syx5
down-regulation on the morphology of the Golgi apparatus and
the transport of vesicles in mammalian cells. Knockdown of the
Syx5 gene resulted in Golgi fragmentation without changing
the level of endoplasmic reticulum (ER)-resident proteins, other
Golgi-SNAREs (soluble N-ethylmaleimide-sensitive factor-
attachment protein receptors), and coatmer proteins. Strikingly,
a major decrease in Syx5 expression barely aﬀected the antero-
grade transport of vesicular stomatitis virus G (VSVG) protein
to the plasma membrane. These results suggest that Syx5 is re-
quired for the maintenance of the Golgi structures but may not
play a major role in the transport of vesicles carrying VSVG be-
tween the ER and the Golgi compartment.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Manymembers of the mammalian syntaxin (Syx) family have
been identiﬁed; most isoforms localize to speciﬁc membrane
compartments along the secretory and endocytotic pathways
and are thought to be involved in the intracellular traﬃcking
of vesicles (reviewed by [1]). The ﬁrst group of Syxs identiﬁed
[Syx1A (HPC-1), 2, 3, and 4] predominantly localize to the plas-
ma membrane; these Syxs may mediate constitutive and regu-
lated exocytotic events at the cell surface [2–6]. Syx5 is resident
in the endoplasmic reticulum (ER)-to-Golgi compartment of
the early secretory pathways [7–9] and has two isoforms (42
and 35 kDa) that are generated from a single messenger RNAAbbreviations: ELISA, enzyme-linked immunosorbent assay; ER,
endoplasmic reticulum; ERGIC/VTC, ER–Golgi-intermediate com-
partment/vesicular tubular carriers; GFP, green ﬂuorescent protein;
GST, glutathione-S-transferase; HA, hemagglutinin; mAb, monoclonal
antibody; RNAi, RNA interference; siRNA, small interfering RNA;
SNARE, soluble N-ethylmaleimide-sensitive factor-attachment protein
receptor; Syx, syntaxin; VSVG, vesicular stomatitis virus ts045 G
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doi:10.1016/j.febslet.2005.06.053through alternative translation in mammalian cells [10]. The
42-kDa form (designated Syx5L) has an amino-terminal exten-
sion containing a type-II ER retrieval signal and preferentially
localizes to the ER, whereas the 35-kDa form (Syx5) localizes
to the cis-Golgi network. Syx5 is thought to regulate the poten-
tial targeting and/or fusion of carrier vesicles at three diﬀerent
membrane fusion interfaces: the fusion of ER-derived vesicles
with transitional ER–Golgi intermediate compartment/vesicu-
lar tubular carriers (ERGIC/VTC), the assembly of ERGIC/
VTCs to form cis-Golgi elements, and the fusion in the intra-
Golgi compartment by the selective combination of a soluble
N-ethylmaleimide-sensitive factor-attachment protein receptor
(SNARE) complex with other SNARE related proteins [7,11–
21]. In addition, in vitro reconstitution experiments show that
Syx5 may also participate in transport from the early/recycling
endosome to the trans-Golgi network (TGN) [22]. These results
indicate that Syx5 may serve as a target-SNARE (t-SNARE)
and play a central role in the transport of membrane vesicles
along the secretory and postTGN/endocytotic pathways.
Although there have been many reports implying important
roles for Syx5 in the transport of vesicles in cell-free systems
and in yeast cells, it has not been examinedwhether Syx5 is indis-
pensable for these functions in mammalian cells. As it seems
likely that the organization of the early secretory compartments
diﬀers across species [23], the role of Syx5 in mammals has to be
explored. In addition, although the precise function is unclear,
others and we have recently shown that Syx5 may have roles
other than vesicle transport in the cell [24–26].
In this study, in order to investigate the physiological signiﬁ-
canceofSyx5,wehaveused theRNAinterference (RNAi)method
(for review, see [27]) to knockdown the expression of the Syx5
gene in mammalian cells. We focused on the eﬀect of Syx5
knockdown on the structure of the Golgi apparatus and the
transport of the vesicular stomatitis virus ts045 G protein. For
the ﬁrst time, using the RNAi method, we demonstrated that
Syx5 is required for themaintenance of the structures of theGol-
gi apparatus but may not play a central role in the anterograde
transport of membrane proteins along the secretory pathway.2. Materials and methods
2.1. Materials and antibodies
Polyethylene glycol and rat monoclonal anti-hemagglutinin (HA)
antibody (3F10) were purchased fromRocheDiagnostics (Indianapolis,
IN, USA). TiterMax Gold was from CytRx Corporation (Norcross,
GA, USA). Murine monoclonal antibodies against BiP/GRP78,
GM130, and c-Adaptin were from BD Transduction Laboratories
(San Diego, CA, USA). Mouse monoclonal anti-a-tubulin antibodyblished by Elsevier B.V. All rights reserved.
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and anti-Membrin antibodies were from Stressgen (Victoria, BC, Can-
ada). Rabbit polyclonal anti-bCOP, anti-EEA1, and anti-LAMP1 anti-
bodies and murine monoclonal anti-SERCA2 antibody were from
Aﬃnity Bioreagents (Golden, CO, USA). Alexa Fluor 488 anti-mouse,
anti-rat, and anti-rabbit IgGs were purchased from Molecular Probes
(Eugene, OR, USA). The Cy3-labelled anti-rat and anti-mouse IgGs
were purchased from Jackson Immunoresearch Laboratories (West
Grove, PA, USA). Hoechst 33342 and Brefeldin A (BFA) were
purchased from Sigma. BFA was stored as a stock solution at 5 mg/ml
methanol. The protease inhibitor cocktail was purchased from Wako
Chemicals (Osaka, Japan). All other reagents were of the highest grade
available, unless otherwise noted.2.2. Plasmids and duplex siRNA
Expression plasmids for the cDNAs encoding the HA-tagged full-
length human syntaxins 1A, 2, 3, 4, 5, 6, 7, and 8 (h1, h2, h3, h4,
h5, h6, h7, and h8) and chimeric mutants of Syx5 and Syx1A were de-
scribed previously [25,26]. The cloning of the cDNAs encoding the
long-splicing isoform of Syx5 (designated as Syx5L) was performed
by generating oligonucleotide primers based on the sequence of cDNA
clone DKFZp313I1240 (EMBL Accession No. BX537426). The di-
gested BamHI–XhoI fragments that contained full-length Syx5L were
inserted into the BamHI–XhoI site of the pcDNA3-HAN vector in
frame to produce h5L-pCDNA3-HAN. The digested BamHI–NotI
fragment that contained a cDNA fragment for aa 1–333 of Syx5L
was inserted into the BamHI–NotI site of pGEX5X-3 vector in frame
to generate h5LDTM-pGEX5X-3. A vesicular stomatitis virus ts045 G
(VSVG)-green ﬂuorescent protein (GFP)-expression plasmid was
kindly provided by Dr. Jennifer Lippincott-Schwartz (Cell Biology
and Metabolism Branch, NICHHD, NICHD, NIH.). A 19-base pair
(bp) sequence for Syx5 (nucleotides 270–288) was selected from the hu-
man Syx5 sequence. The small interfering RNAs (siRNAs) corre-
sponding to the Syx5 sequence and its scrambled sequence with an
additional two-base 3 0 overhang (TT) on each strand were obtained
from Ambion (Austin, TX, USA). The sequence of Syx5 siRNA
was: 5 0-UAGCCUCAACAAACAAAUUTT-3 0 for the sense and 5 0-
AAUUUGUUUGUUGAGGCUATT-3 0 for the antisense strands.
The sequence of the scrambled siRNA was: 5 0-UGUACAAAUCA-
CACCAUAATT-3 0 for the sense and 5 0-UUAUGGUGUGAUUU-
GUACATT-3 0 for the antisense strands. The annealing of duplex
siRNAs was performed according to the manufacturers protocol.
An expression vector for Syx5 siRNA was constructed using a Silen-
cereExpress kit (Ambion). Brieﬂy, oligonucleotides containing sense
and antisense strands of the Syx5 sequence (nucleotides 270–288), loop
region, RNA polymerase III promoter and terminator sequences, and
BamHI and HindIII restriction enzyme sites were chemically
synthesized, annealed, and cloned into the BamHI and HindIII sites
of pSilencer 3.1-H1 neo vector. The pSilencer 3.1-H1 neo vector was
used as a negative control. The plasmids for the deletion mutants of
Syx5 fused to glutathione-S-transferase (GST) [h5DTM (1–279),
h5DH3-pGEX5X-3 (1–204), h5Habc-pGEX5X-3 (1–158), h5Dhab3-
pGEX5X-3 (113–204), h5Hab-pGEX5X-3 (1–112), h5DHabc-
pGEX5X-3 (159–279), and h5H3-pGEX5X-3 (204–279)] were
described previously [26]. Additional plasmids, h5DHa3-pGEX5X-3
(66–204), h5Hbc-pGEX5X-3 (66–158), h5Hc-pGEX5X-3 (113–158),
h5Hinge-pGEX5X-3 (159–204), h5Ha-pGEX5X-3 (66–279), and
h5DHab-pGEX5X-3 (113–279), were constructed in a similar manner.
The identities of the inserted sequences were veriﬁed for the constructs,
both by direct sequencing using the ABI373A sequencer with the Big-
Dye ﬁlter (Applied Biosystems) and by digestion with the appropriate
restriction enzymes.2.3. Cell culture and transfection
PC12, HeLa, COS-7, and NG108-15 cells were cultured as described
previously [25,26,28]. The cells were inoculated into 60-mm dishes for
Western blotting or 35-mm dishes with glass bottoms for the immuno-
cytochemical analyses. The cells were transfected with the duplex siR-
NA or the siRNA expression plasmid using Lipofectamine 2000
transfection reagent (Invitrogen, Groningen, The Netherlands) or Fu-
Gene6 transfection reagent (Roche Diagnostics), respectively. Two
days after transfection, the cells were subjected to Western blotting
or immunocytochemical analysis.2.4. Expression and puriﬁcation of GST-fusion proteins
To express the recombinant GST-fusion proteins, plasmids encoding
GST-fused deletion mutants of Syx5 were transformed into Escherichia
coli strain BL21 (Stratagene). The puriﬁcation of GST-fusion proteins
from bacterial lysates was performed as described previously [26,28].
2.5. Production of monoclonal antibodies against Syx5
The puriﬁed GST-h5DTM was used for immunization. Six-to-eight-
week-old BALB/c mice (Clea Japan, Tokyo, Japan) were immunized
with puriﬁed GST-h5DTM (20 lg protein/mouse) in buﬀer containing
1% SDS emulsiﬁed with an equal volume of TiterMax Gold by i.p.
injection three times at 2-week intervals. Spleen cells were fused with
PAI mouse myeloma cells using the polyethylene glycol method as de-
scribed previously [28]. The hybridomas were selected in medium con-
taining 2.5 mM hypoxanthine, 10 lM aminopterin, 0.4 mM thymidine,
and were cultured in RPMI-1640 medium containing 20% fetal calf
serum (FCS). Culture supernatants from the hybridoma cultures were
screened by enzyme-linked immunosorbent assay (ELISA), Western
blotting, and an indirect immunoﬂuorescent method. Puriﬁed GST-
fusion proteins of Syx5 (Fig. 1A) and lysates from HeLa cells were
used as antigens for the ELISA and Western blotting. Positive hybrid-
oma cells were cloned from a single clone that was derived by the lim-
iting dilution method. Antibody classes were identiﬁed with the Mouse
Monoclonal Antibody Isotyping kit RPN29 (Amersham Biosciences).
Ascites ﬂuid was produced from BALB/c mice that had been implanted
intraperitoneally with the hybridoma. The IgG fraction was obtained
by aﬃnity chromatography on protein G–Sepharose 4FF (Amersham
Biosciences) as described previously [28].
2.6. Extract preparation, SDS–PAGE, and Western blotting
Cells transfected with duplex siRNA were harvested with a cell scra-
per, recovered by centrifugation, lysed in extraction buﬀer (50 mM
Tris/HCl, pH 7.5, 0.15 M NaCl, and 1% Triton X-100) containing a
protease inhibitor cocktail, and then sonicated for 30 s. The insoluble
material was removed by centrifugation at 15,000 · g for 10 min, and
the supernatant was used as the extract sample. The samples were
subjected to SDS–PAGE followed by Western blotting as described
previously [25,28].
2.7. Immunocytochemical analysis
Immunocytochemical analyses were carried out essentially as de-
scribed previously [25,26].
2.8. VSVG transport assay
Cells were plated on a 35-mmdishwith a glass bottom and transfected
with 30 nM of duplex siRNA. Twenty-four hours after transfection, the
cellswere transfectedwith theVSVG-GFP-expressionplasmid and incu-
bated for 14–16 h at 40 C. The cells were then incubated for the indi-
cated times at 32 C and subjected to immunocytochemical analyses.
In the case of Syx5 overexpression, the cells were co-transfected with
h5-pcDNA3-HAN and the VSVG-GFP-expression plasmid and incu-
bated for 14–16 h at 40 C prior to the temperature shift to 32 C. The
inhibition by BFA of VSVG-GFP transport from ER to the Golgi com-
partment was conﬁrmed by a time-lapse imaging experiment. In brief,
cells grown in a 35-mmdishwith a glass bottomwere supplemented with
Hanks Balanced Salt Solution containing 20 mMHEPES, pH 7.4, and
0.05%BSA (HHBbuﬀer), and the temperature wasmaintained at 32 C.
The cells were visualized under an invertedmicroscope (IX70, Olympus)
with a 60· PlanApo lens (numerical aperture, 1.4 oil) using a standard
ﬁlter set. Sequential images were acquired with a cooled CCD camera
(CoolSNAP, Roper Scientiﬁc, Trenton, NJ, USA) under the control of
Metamorph software (Universal Imaging, Downingtown, PA, USA).
BFA treatment was performed by applying HHB buﬀer containing
BFA to give a ﬁnal concentration of 10 lg ofBFAperml in a culture dish
placed on the stage.3. Results
3.1. Generation and epitope mapping of a mAb speciﬁc for Syx5
Inorder to examine thephysiological role of Syx5,weﬁrst pro-
duced the speciﬁc monoclonal antibody 1C5 to Syx5. Syx5 is
Fig. 1. Characterization of a monoclonal antibody speciﬁc for Syx5. (A) Schematic of the GST-fusion proteins of the Syx5L and Syx5
transmembrane deletion mutants. The putative a-helices (Ha, Hb, Hc, and H3 domains) of Syx5 are indicated in black. The putative transmembrane
region of Syx5 (aa 280–301) is omitted. Recombinant GST-h5DTM protein was expressed in E. coli, puriﬁed, and used for immunization and
screening of hybridomas by ELISA under non-denaturing conditions and by Western blot analysis under SDS-denaturing conditions. The numbers
are those of amino acid residues. (B) Epitope mapping of mAb 1C5 by ELISA under non-denaturing conditions using the various truncation mutants
of Syx5 shown in (A). The culture supernatant of hybridoma producing mAb 1C5 was used, and the absorbance at 450 nm is presented. Note that
polypeptides containing amino acid residues 1–66 reacted with 1C5. (C) Puriﬁed GST and GST-h5DTM protein were subjected to SDS–PAGE
followed by immunoblotting. Note that, under SDS-denaturing conditions, the mAb 1C5 reacted with GST-h5DTM but not with GST. (D) An
alignment of amino acid sequences containing the 1C5 epitope in human (h), rat (r), and mouse (m) Syx5. NCBI accession numbers are as follows:
Q13190(hSyx5), F48213 (rSyx5), and Q8K1E0 (mSyx5). (E) Western blot analyses were performed with endogenous Syx5 expressed in various cell
lines. Total cellular protein (40 lg) extracted from a given cell line (as indicated) was subjected to immunoblotting. Note that the mAb 1C5 recognizes
rat, human, monkey, and mouse Syx5 isoforms. (F) Speciﬁcity of mAb 1C5 for Syx5. HeLa cells were transfected with various human Syxs and
subjected to immunoblotting. The gels are representative of those obtained from at least three independent experiments. Arrows and arrowheads
indicate expressed HA-tagged Syx5L and Syx5, respectively. Endogenous Syx5 and Syx5L were labelled in all lanes (h1A-h8) by mAb 1C5. The mAb
1C5 speciﬁcally recognized Syx5 and Syx5L but does not react with the other Syxs.
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Hb, Hc, and H3 domains) and a putative C-terminal membrane
anchor region (Fig. 1A). For the epitope mapping of 1C5, vari-
ous truncation mutants of GST-fused Syx5 were generated
(Fig. 1A). ELISA analysis using puriﬁed GST-fusion proteins
of Syx5 revealed that the epitope of 1C5 maps to aa 1–66 from
the N-terminus (Fig. 1B). Although 1C5 did not react with
GST-h5DTM in the non-denatured condition (ELISA analysis),
Western blotting analyses under denaturing conditions revealed
that 1C5 does react with GST-h5DTM (Fig. 1C). The reactivity
of 1C5 to the N-terminal region (aa 1–66) of GST-fused Syx5
was conﬁrmed by Western blot analyses (data not shown). In
addition, 1C5 reacted with Syx5L under non-denaturing (ELI-
SA analysis in Fig. 1B) and denaturing conditions (Western blot
analysis, data not shown). As Syx5 is highly conserved among
mammals (Fig. 1D), we examined the cross-reactivity of 1C5
to Syx5 of other species. As shown in Fig. 1E, the results from
Western blotting showed that 1C5 recognizes Syx5 of humans,
rat, mouse, and monkey. To further establish the speciﬁcity ofmonoclonal antibody (mAb) 1C5, various human Syxs were ex-
pressed, and the reactivity of 1C5 to other Syxs was analyzed. As
shown in Fig. 1F, 1C5 recognized Syx5 and Syx5L but not the
other Syxs studied so far. These results demonstrate the speciﬁc-
ity of mAb 1C5 for the N-terminal region containing the Ha
domain of Syx5 of various species.
3.2. Knockdown of syntaxin 5 by RNAi method
To reduce the amount of endogenous Syx5 in cells, an RNAi
technique was used. Two diﬀerent target sequences were
synthesized and tested for the eﬃciency of Syx5 knockdown
by immunoblotting and immunocytochemical analyses. As
shown in Fig. 2A, one of the siRNAs eﬃciently decreased
the amount of endogenous Syx5s in HeLa cells. The dose-
dependent inhibition of the expression of Syx5s was clearly
observed by immunoblotting. Densitometric analysis showed
that, when 30 nM of duplex siRNA was used, the amount of
Syx5s was decreased to less than 15% of that in control cells.
It is noteworthy that both short and long isoforms of Syx5
Fig. 2. Knockdown of Syx5 by RNAi. (A) HeLa cells were transfected
with the indicated doses of duplex siRNA for Syx5 or the scrambled
duplex. Two days after transfection, the cells were extracted and
subjected to Western blotting with a mAb to Syx5 (1C5). Knockdown
by siRNA dose-dependently decreased the amount of Syx5 protein. (B)
Knockdown of Syx5 was assessed by an indirect immunoﬂuorescence
method using mAb 1C5 antibody. Immunoreactivity of Syx5 is absent
in knockdown cells. (C) Speciﬁc knockdown of Syx5. Syx5 knockdown
cells (transfected with 30 nM siRNA) were subjected to Western
blotting with the indicated marker proteins for the ER, ERGIC/VTC,
and Golgi apparatus. BiP/GRP78 and SERCA2 were used as markers
for the ER; bCOP was used for the ERGIC and Golgi apparatus;
GM130 was used for the cis-Golgi network; Membrin was used for the
Golgi apparatus; and c-Adaptin was used for the trans-Golgi network.
a-Tubulin was used as a loading control. The gels and images are
representative of those obtained from at least three independent
experiments. Syx5 RNAi did not aﬀect the expressed amounts of
representative marker proteins of the ER and Golgi compartments.
Bar, 10 lm.
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(Fig. 2A, right panel). The amount of remaining Syx5 proteins
in cells transfected with siRNA expression-plasmid was de-
creased to approximately 35% of that in control vector trans-
fected cells. The immunocytochemical analysis shown in
Fig. 2B demonstrated that Syx5s resident in the vesicles and
the Golgi apparatus (as can be seen in control cells) were
diminished in the RNAi-induced cells.
Selective knockdown of Syx5 with speciﬁc siRNA was
conﬁrmed by immunoblotting. We examined the amounts of
proteins located in the ER, the ER–Golgi-intermediate-
compartment (ERGIC/VTC), and the Golgi apparatus in
Syx5 knockdown cells (Fig. 2C). As assessed by the marker
for the ER (BiP/GRP78, SERCA2), the marker for the ER-
GIC/VTC and Golgi apparatus (bCOP), the marker for the
cis-Golgi network (GM130), and the marker for the trans-
Golgi network (c-Adaptin) [29,30], the expression of Syx5 siR-
NA did not change the cellular levels of representative proteins
from the ER through the Golgi apparatus. It is important to
note that the expression level of Membrin (a binding partner
of Syx5) was not changed by the down-regulation of Syx5s.Similar results were also found in cells transfected with the siR-
NA-expression plasmid (data not shown).
Next, we examined the eﬀect of Syx5s overexpression on the
amounts of marker proteins in the ER through the Golgi appa-
ratus. HeLa cells were transfected with either HA-tagged Syx5
or Syx5L and analyzed by immunoblotting. Similar to the lev-
els in knockdown cells, the cellular levels of the representative
proteins from the ER through the Golgi apparatus were not af-
fected (data not shown). The change in the amount of Syx5
was protein-speciﬁc, as cellular levels of the tested marker pro-
teins for the ER, ERGIC/VTC, and Golgi apparatus were not
altered in HeLa cells.
3.3. Eﬀect of syntaxin 5 knockdown and overexpression on
structures of the Golgi apparatus
Although the alteration of the amount of Syx5hadno eﬀect on
the cellular expression of the marker proteins for the ER,
ERGIC, andGolgi apparatus, it might aﬀect their speciﬁc intra-
cellular localization. Therefore, we investigated immunocyto-
chemically the intracellular localization of the proteins (used
inFig. 2) in cells inwhichSyx5was knockeddownoroverexpres-
sed. As shown in Fig. 3A, the intracellular localization of SER-
CA2 (a marker for the ER) did not diﬀer in cells treated with the
siRNA expression plasmid. However, the immunoreactivity of
bCOP,GM130,Membrin,GS28, and c-Adaptin, all ofwhich re-
side in theGolgi apparatus, were scattered. It is noteworthy that
the localization of the Golgi SNAREsMembrin and GS28 were
altered by Syx5 knockdown. To conﬁrm that these changes in
localization were attributable to Syx5 down-regulation, cells
were doubly stained with 1C5 and anti-bCOP antibody. We
found that bCOP was dispersed as a vesicular structure in more
than 95%of the cells inwhich Syx5was down-regulated (Fig. 3B,
upper panels). So, it was obvious that all most all the Syx5
knockdown cells revealed dispersed bCOP immunoreactivity.
Given that bCOP reﬂects the localization of the COPI vesicle,
we investigated the correlation between bCOP (and Syx5) local-
ization and the structure of the Golgi apparatus by using the
Golgimatrix proteinGM130,which functions as a tethering fac-
tor at the face of the cis-Golgi [30]. As shown in the bottom pan-
els in Fig. 3B, over 95% of the cells that showed dispersed bCOP
were associated with the dispersion of GM130 immunoreactiv-
ity. Similarly, other proteins that reside in the Golgi apparatus
(Membrin, GS28, and c-Adaptin) were also scattered when co-
localization were examined with bCOP (data not shown). In
agreementwith the results obtained inHeLa cells, similar disper-
sion of bCOP and GM130 induced by the down-regulation of
Syx5was observed inNG108-15 cells and in cultured hippocam-
pal neurons (data not shown). However, Syx5 knockdown did
not alter the intracellular localization of early-endosomal anti-
gen 1 (EEA1) and the lysosome associated membrane protein
1 (LAMP1) indicating that Syx5 depletion may mot aﬀect
post-TGN, endosomal, and lysosomal systems (data not
shown). These results suggest that Syx5 depletion causes the
fragmentation of the Golgi apparatus but the tethering of COPI
vesicles is normal, at least in the cis-Golgi network.
We also investigated the eﬀects of Syx5 overexpression on the
intracellular localization of bCOP andGM130. In cells in which
Syx5 was overexpressed (Fig. 3C), bCOPwas dispersed as vesic-
ular structures and was associated with the fragmentation of the
Golgi apparatus as assessed by GM130. These results suggest
that the amount of Syx5 is critical for the maintenance and/or
organization of the structure of the Golgi apparatus.
Fig. 3. Eﬀect of Syx5 knockdown and overexpression on the structure of the ER and Golgi apparatus. (A) HeLa cells were transfected with an
siRNA-expression plasmid and subjected to immunocytochemistry with the indicated antibodies. While the localization of the ER marker (SERCA2)
was normal, the markers representing the Golgi apparatus (bCOP, GM130, GS28, Membrin, and c-Adaptin) showed dispersed morphology of Golgi
in the cells indicated by arrows. (B) Cells transfected with duplex siRNA were subjected to double-immunoﬂuorescence immunocytochemistry with
anti-bCOP antibody and 1C5 or anti-GM130 antibody. Hoechst33342 staining is shown in blue. Representative images are shown. The merged
images demonstrate the co-localization of bCOP with Syx5 and GM130, and the fragmentation of the Golgi apparatus in Syx5 knockdown cells
(arrowheads). (C) Cells transfected with HA-tagged Syx5-expressing plasmid were subjected to double-immunoﬂuorescence immunocytochemistry.
Overexpressed Syx5 was detected with anti HA antibody (3F10) and was stained with antibody for bCOP or GM130. Representative images are
shown. Arrowheads indicate the Syx5-overexpressing cells showing the dispersion of bCOP-positive vesicles (upper panels) and the fragmentation of
the Golgi apparatus (bottom panels). The cells with asterisks indicate cells which have morphologically normal bCOP localization and Syx5
expression appeared to be unchanged in these cells. Images in the right columns show magniﬁed views of boxed areas. Bars, 10 lm.
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Syx5 has been suggested to act as a t-SNARE involved in
vesicular transport between the ER and Golgi. Therefore, we
examined the eﬀects of Syx5 on the transport of a tempera-
ture-sensitive mutant of vesicular stomatitis virus ts045-Gprotein (VSVGts045) as a model transmembrane glycoprotein
that is normally traﬃcked along the secretory pathways
[31,32]. As has been reported [33,34], the treatment of cells
with a fungal toxin, BFA, that speciﬁcally inhibits the trans-
port of vesicles from the ER to the Golgi apparatus led to
Fig. 4. Eﬀect of Syx5 knockdown on vesicle traﬃcking. (A) COS-7 cells transfected with a VSVG-GFP expression plasmid were treated with BFA (at
2 min), and consecutive images were taken of the same cells. (B) COS-7 cells were transfected with the scrambled duplex siRNA followed by
transfection with a VSVG-GFP-expressing plasmid. The transfected cells were maintained at 40 C for 14–16 h, shifted to 32 C, and incubated for
the indicated times. After ﬁxation at each time point, the cells were subjected to immunocytochemistry. (C) Cells were transfected with duplex siRNA
of Syx5, and an experiment similar to that described in (B) was performed. Upon shifting to the permissive temperature, VSVG-GFP was transported
from the ER to the Golgi apparatus in 30 min and was ﬁnally transported to the plasma membrane in 120 min both in control (B) and knockdown
cells (C), whereas the transportation of VSVG-GFP along the secretory pathway was signiﬁcantly inhibited in BFA-treated cells, as shown in (A).
Insets show magniﬁed views of boxed areas. Bars, 10 lm.
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(VSVG-GFP) in the ER (Fig. 4A). Fragmentation of the Golgi
was also detected in cells in which Syx5 was overexpressed
(Fig. 3C); therefore, we also investigated the eﬀects of Syx5
overexpression on the transport of VSVG-GFP. As was found
in other cells [7], when Syx5 was overexpressed in HeLa cells,
VSVG-GFP was predominantly retained in the ER at 30 min
after the shift to the permissive temperature, while VSVG-
GFP strictly localized at the Golgi apparatus in control cells
(data not shown). In cells in which Syx5 was overexpressed,
the retention of VSVG-GFP in the ER, ERGIC/VTC, and
Golgi apparatus persisted for over 2 h after the temperature
shift (data not shown). These results suggest that the excess
Syx5 expression interferes with the anterograde transport of
vesicles in the ER and Golgi compartments.
In a ﬁnal series of experiments, COS-7 cells were transfected
with siRNA followed by a plasmid expressing VSVG-GFP,
and the transport was analyzed. In control cells transfected
with scrambled siRNA, VSVG-GFP was localized in the ER
at the nonpermissive temperature (time, 0 min); after shifting
to the permissive temperature, VSVG-GFP was transported
to the Golgi apparatus (time, 30 min) and ﬁnally to the plasma
membrane at 120 min (Fig. 4B). To our surprise, in Syx5
knockdown cells, VSVG-GFP was eﬃciently transported from
the ER to the plasma membrane (Fig. 4C). The population ofcells of which plasma membrane were VSVG-GFP-positive at
time 120 min were 83% and 85% in control and Syx5 knock-
down cells, respectively. As can be seen in Fig. 4B and C,
although VSVG-GFP was localized to the fragmented Golgi,
VSVG-GFP was capable of transport along the secretory path-
way in COS-7 cells. While, at 30 min, 90% of the VSVG-posi-
tive cells treated with scrambled siRNA showed VSVG
localization in ribbon-like structures, 89% of the VSVG-posi-
tive cells treated with Syx5 siRNA showed VSVG localization
in fragmented structures. These VSVG location were well co-
localized with the GM130 positive Golgi fragments (data not
shown). Similar results were obtained in HeLa cells transfected
with either duplex siRNA or a plasmid expressing siRNA
(data not shown). The transport of VSVG-GFP across the
Golgi compartment was not diminished by the major decrease
in Syx5 that is associated with Golgi fragmentation.4. Discussion
In order to show the physiological signiﬁcance of Syx5 in
cellular function, we have generated a novel monoclonal
antibody speciﬁc to Syx5 and have analyzed the Golgi struc-
tures and vesicle transport along the secretory pathway un-
der two sets of conditions. One of these is the knockdown
4232 K. Suga et al. / FEBS Letters 579 (2005) 4226–4234of the expression of the Syx5 gene by an RNA interference
method, and the other is Syx5 overexpression. Remarkably,
we found that Syx5 depletion by RNAi results in extensive
fragmentation of the Golgi apparatus (Fig. 3), supporting
a role for Syx5 in the maintenance of Golgi architecture.
In support of this idea, reassembly experiments of Golgi
stacks in a cell-free system revealed that Syx5 is likely to
be involved in the organization of Golgi cisternae at mitosis
[12]. The absence of Syx5 may aﬀect the biogenesis of the
Golgi apparatus in cooperation with other vesicle transport
regulator proteins or protein complexes that interact with
Syx5. One such candidate is rSly1 [35], a member of the
nSec-1/munc18 (SM) group of proteins, because it has been
shown that blocking rSly1 binding to Syx5 results in the dis-
ruption of the Golgi apparatus [36]. In addition, studies
in vitro showed that rSly1 binding to Syx5 is required for
ER-to-Golgi transport [37]. Another candidate is the p115
protein, which tethers COPI vesicles to the Golgi membrane
and is essential for the functioning of the Golgi apparatus
[38]. It has also been demonstrated that the p115 protein
directly interacts with Golgi SNAREs, including Syx5, and
catalyzes SNARE complex assembly [39]. Other candidates
are conserved oligomeric Golgi (COG) complexes, which
are suggested to be necessary for the membrane traﬃcking
modulated by COPI and were shown to interact with COPI
and the Golgi SNARE GS28 [40]. The immunoreactivity of
bCOP and GM130 co-localized in Syx5 knockdown cells
(Fig. 3B, merged images), indicating that COPI vesicles
might be capable of tethering to the fragmented Golgi. Fur-
thermore, similar to the results seen in other cells [40],
these fragmented Golgi might be competent for the antero-
grade transport of membrane proteins, at least for VSVG
transport.
Although it is still not clear if COPs act directly or indirectly
in the anterograde or retrograde direction in the ER, ERGIC/
VTC, and Golgi compartment [41–43], VSVG protein can
potentially enter COPI and COPII vesicles [31,44,45]. A num-
ber of reports have shown that Syx5 and VSVG are co-local-
ized in the same COP-coated vesicles [7,13,46–48].
Furthermore, the distribution and combinatorial speciﬁcity
of yeast and mammalian SNARE complexes containing Syx5
mediate the ﬂow and the fusion of COP vesicles
[10,18,21,49–54]. As all of these ﬁndings imply a signiﬁcant
role of Syx5 in intracellular vesicle transport, the lack of a
marked eﬀect of Syx5 knockdown on anterograde transport
of VSVG was striking. Although some minor traﬃcking de-
fects and/or kinetic delays in the transport of VSVG from
the ER to the plasma membrane cannot be excluded, the ﬁnd-
ing that the majority of VSVG reaches the plasma membrane
indicates that Syx5 may not be indispensable for the antero-
grade ﬂow of some membrane proteins, at least VSVG-con-
taining vesicles, along the secretory pathways. In mammalian
cells, it is possible that undeﬁned proteins, other than Syx5,
may compensate for Syx5 in the transport of vesicles in the
ER through Golgi compartments. Molecular redundancy of
SNARE proteins in ER–Golgi transport has been reported
in yeast cells [55]. Accordingly, further experiments in Syx5
knockdown cells examining whether other Syxs and/or
SNAREs are upregulated and functionally substitute for
Syx5 are required. It has been reported that Membrin, another
Golgi SNARE that binds to Syx5, is involved in the targeting
of ADP-ribosylation factor-1 (Arf-1) to the early phase of theGolgi [56]. It is noteworthy that the action of Membrin on the
interaction and distribution of Arf-1 suggests an additional
role of Membrin distinct from the function mediated by the
SNARE complex. Our results also indicate the signiﬁcance
of Syx5 in cellular functions other than t-SNARE and raise
the possibility that the SNARE hypothesis may have to be
reconsidered. In future studies, by using Syx5 knockdown
cells, precise investigation of the mechanism of Golgi fragmen-
tation and vesicle transport mediated by SNARE complex for-
mation is needed. In addition, it would be of interest to
examine whether there is any defect in the retrograde transport
of vesicles from the Golgi to the ER in Syx5 knockdown cells.
A Syx5-ablated cell might be useful for clarifying the role of
Syx5 and for the investigation of SNARE function as well as
Syx5 functions distinct from SNARE.
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